Syndax Pharmaceuticals Reports Fourth Quarter 2019 Financial Results and Provides Clinical and Business Update
Go back to Syndax Pharmaceuticals Reports Fourth Quarter 2019 Financial Results and Provides Clinical and Business Update| HERCULES TECHNOLOGY GROWTH CAPITAL, Inc. (NYSE: HTGC) | Delayed: 15.18 -0.05 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.23 | 52 Week High | $14.00 | |||
| Open | $15.15 | 52 Week Low | $9.92 | |||
| Day High | $15.34 | P/E | 8.63 | |||
| Day Low | $15.11 | EPS | $1.76 | |||
| Volume | 1,286,584 | |||||
| (NASDAQ: SNDX) | Delayed: 19.61 +0.29 (1.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.32 | 52 Week High | $18.03 | |||
| Open | $19.32 | 52 Week Low | $8.97 | |||
| Day High | $20.00 | P/E | N/A | |||
| Day Low | $19.21 | EPS | $0.00 | |||
| Volume | 1,015,623 | |||||
